Brief: Yichang Hec Changjiang Pharmaceutical Says HY Revenue Rmb3,209.0 Mln
Aug 31 (Reuters) - YiChang HEC ChangJiang Pharmaceutical
Co Ltd 1558.HK :
* HY REVENUE RMB3,209.0 MILLION, AN INCREASE OF 148.1% FROM
PCP
* HY PROFIT AND TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE
RMB1,029.5 MILLION VERSUS LOSS RMB32.8 MILLION
* RESOLVED NOT TO DECLARE PAYMENT OF AN INTERIM DIVIDEND
Source text for Eikon: ID:nHKS2fc5bj
Further company coverage: 1558.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million